Neuromuscular disorders in the spotlight: highlights and expert commentary on WMS 2021

The World Muscle Society’s virtual congress (WMS 2021), held on 20-24 September, included lively debate sessions and new data that could help optimize the diagnosis and treatment of neuromuscular disorders.

Here, Professor Laurent Servais (University of Oxford, UK, and member of the WMS 2021 program committee) provides commentary on a selection of the most important presentations, discussing their potential impact on care.

Click on the links in the text for more details of the presentations, from Neurodiem’s daily coverage of the event.

WMS 2021 got off to a dynamic start with a series of expert debates on the first day, addressing issues across the continuum from translational research to clinical research and practice. One addressed the issue of whether pre-conception carrier screening (PCS) or newborn screening (NBS) is preferred for the detection of neuromuscular disorders such as spinal muscular atrophy (SMA).